Literature DB >> 17385388

Noninvasive diagnostic strategies for peripheral arterial disease.

Susan M Begelman1, Michael R Jaff.   

Abstract

A variety of diagnostic methods for peripheral arterial disease (PAD) are available, each with strengths and limitations. The ankle-brachial index is a simple and useful screening tool for PAD that can be performed in the office setting. Segmental limb pressure examinations and pulse volume recordings aid in identifying the location of disease. Pulse volume recordings are especially useful, along with the ankle-brachial index, in assessing functional status during exercise. Duplex ultrasonography, magnetic resonance angiography, and computed tomographic angiography are helpful in providing anatomic detail and thus yield additional information for planning interventional therapy. Conventional angiography, the "gold standard" study for PAD diagnosis, is now usually pursued only once an intervention is planned.

Entities:  

Mesh:

Year:  2006        PMID: 17385388     DOI: 10.3949/ccjm.73.suppl_4.s22

Source DB:  PubMed          Journal:  Cleve Clin J Med        ISSN: 0891-1150            Impact factor:   2.321


  12 in total

Review 1.  Clinical implications of skeletal muscle blood-oxygenation-level-dependent (BOLD) MRI.

Authors:  Sasan Partovi; Sasan Karimi; Bjoern Jacobi; Anja-Carina Schulte; Markus Aschwanden; Lisa Zipp; John K Lyo; Christof Karmonik; Matthias Müller-Eschner; Rolf W Huegli; Georg Bongartz; Deniz Bilecen
Journal:  MAGMA       Date:  2012-02-29       Impact factor: 2.310

2.  Diagnosis of peripheral arterial disease of the lower limb.

Authors:  Andrew W Bradbury; Donald J Adam
Journal:  BMJ       Date:  2007-06-16

Review 3.  Noninvasive Arterial Testing: What and When to Use.

Authors:  Derek Mittleider
Journal:  Semin Intervent Radiol       Date:  2019-02-05       Impact factor: 1.513

4.  The prevalence of peripheral arterial disease in korean patients with type 2 diabetes mellitus attending a university hospital.

Authors:  Ji Hee Yu; Jenie Yoonoo Hwang; Mi-Seon Shin; Chang Hee Jung; Eun Hee Kim; Sang Ah Lee; Eun Hee Koh; Woo Je Lee; Min-Seon Kim; Joong-Yeol Park; Ki-Up Lee
Journal:  Diabetes Metab J       Date:  2011-10-31       Impact factor: 5.376

5.  MRI of arterial flow reserve in patients with intermittent claudication: feasibility and initial experience.

Authors:  Bas Versluis; Marjolein H G Dremmen; Patty J Nelemans; Joachim E Wildberger; Geert-Willem Schurink; Tim Leiner; Walter H Backes
Journal:  PLoS One       Date:  2012-03-08       Impact factor: 3.240

6.  Dynamic contrast-enhanced MRI assessment of hyperemic fractional microvascular blood plasma volume in peripheral arterial disease: initial findings.

Authors:  Bas Versluis; Marjolein H G Dremmen; Patty J Nelemans; Joachim E Wildberger; Geert-Willem Schurink; Tim Leiner; Walter H Backes
Journal:  PLoS One       Date:  2012-05-25       Impact factor: 3.240

7.  A New 2D-Based Method for Carotid Intima-Media Thickness Quantification From Ultrasound Sequences.

Authors:  Mehravar Rafati; Mehrdad Rafati Rahimzadeh; Fariba Raygan; Vahid Nikseresht; Hassan Moladoust
Journal:  Iran Red Crescent Med J       Date:  2015-03-31       Impact factor: 0.611

8.  Functional MRI in peripheral arterial disease: arterial peak flow versus ankle-brachial index.

Authors:  Bas Versluis; Patty J Nelemans; Rutger Brans; Joachim E Wildberger; Geert-Willem Schurink; Tim Leiner; Walter H Backes
Journal:  PLoS One       Date:  2014-02-05       Impact factor: 3.240

9.  In vivo measurements of regional hemoglobin oxygen saturation values and limb-to-arm ratios of near-infrared spectroscopy for tissue oxygenation monitoring of lower extremities in healthy subjects.

Authors:  Reinout Pe Boezeman; Johannes C Kelder; Frans Gj Waanders; Frans L Moll; Jean-Paul Pm de Vries
Journal:  Med Devices (Auckl)       Date:  2014-12-29

10.  Disease location is associated with survival in patients with peripheral arterial disease.

Authors:  Qian Chen; Carin Y Smith; Kent R Bailey; Paul W Wennberg; Iftikhar J Kullo
Journal:  J Am Heart Assoc       Date:  2013-10-21       Impact factor: 5.501

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.